Sapporo, Japan

Satoshi Nishizawa



Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Hokkaido, JP (2013)
  • Sapporo, JP (2016 - 2022)

Company Filing History:


Years Active: 2013-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Satoshi Nishizawa

Introduction

Satoshi Nishizawa is a prominent inventor based in Sapporo, Japan. He has made significant contributions to the field of cancer research, particularly in the development of molecular markers for cancer stem cells. With a total of four patents to his name, Nishizawa's work is pivotal in advancing cancer diagnostics and treatment.

Latest Patents

Nishizawa's latest patents focus on a molecular marker for detecting cancer stem cells in cell masses. This molecular marker can be identified in cancer stem cells but not in normal cells or other types of cancer cells. His patents include methods for determining the presence of cancer stem cells using this marker, as well as kits designed for detection. Additionally, his innovations encompass a polypeptide encoded by the molecular marker, antibodies that recognize specific epitopes, nucleic acids that inhibit the expression of the marker, and a nucleic acid vaccine derived from the marker.

Career Highlights

Throughout his career, Satoshi Nishizawa has worked with esteemed institutions such as Sapporo Medical University and Sumitomo Dainippon Pharma Co., Ltd. His research has been instrumental in enhancing the understanding of cancer biology and improving diagnostic techniques.

Collaborations

Nishizawa has collaborated with notable colleagues, including Toshihiko Torigoe and Yoshihiko Hirohashi. These partnerships have contributed to the advancement of his research and the development of innovative solutions in cancer treatment.

Conclusion

Satoshi Nishizawa's contributions to cancer research through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in cancer diagnostics and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…